Free shipping on all orders over $ 500

 About 1 result found for searched term "2460809-80-5" (0.145 seconds)

Cat.No.  Name Target
M25173 Burfiralimab IL Receptor/Related
hzVSF-v13
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.